MEF-2C, or myocyte enhancer factor 2C, belongs to the MEF-2 family of transcription factors, which play crucial roles in regulating gene expression programs involved in various cellular processes, including differentiation, proliferation, and survival. Specifically, MEF-2C is predominantly expressed in cardiac and skeletal muscle tissues, where it serves as a master regulator of muscle development and function. Functionally, MEF-2C orchestrates the expression of genes involved in muscle differentiation, contractility, and metabolism, thereby contributing to the formation and maintenance of muscle tissue. Additionally, MEF-2C has been implicated in neuronal development and synaptic plasticity, underscoring its diverse roles beyond muscle biology.
Activation of MEF-2C involves complex regulatory mechanisms that integrate diverse signaling pathways and cellular cues. One major mechanism of MEF-2C activation involves its phosphorylation by various kinases, including calcium/calmodulin-dependent protein kinases (CaMKs), mitogen-activated protein kinases (MAPKs), and protein kinase D (PKD). Phosphorylation of MEF-2C promotes its nuclear translocation and transcriptional activity by modulating its DNA-binding affinity and interaction with co-regulatory proteins. Furthermore, MEF-2C activity can be regulated by post-translational modifications such as acetylation, methylation, and sumoylation, which influence its stability, subcellular localization, and interactions with other proteins. Additionally, MEF-2C activity can be modulated by signaling pathways activated by extracellular cues, including growth factors, hormones, and mechanical stimuli, which converge on intracellular signaling cascades that ultimately regulate MEF-2C transcriptional activity. Overall, the activation of MEF-2C is a tightly regulated process essential for coordinating gene expression programs critical for muscle development, function, and adaptation to environmental stimuli.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542 is a selective inhibitor of the TGF-β receptor ALK5, blocking TGF-β signaling. By inhibiting ALK5, SB431542 disrupts the TGF-β pathway, potentially influencing MEF-2C activation. | ||||||
XMD 8-92 (free base) | 1234480-50-2 | sc-364068 sc-364068A sc-364068B sc-364068C | 5 mg 10 mg 100 mg 1 g | $235.00 $340.00 $1700.00 $10330.00 | 10 | |
XMD8-92 is a selective inhibitor of the myocyte enhancer factor 2 (MEF2) family of transcription factors. It disrupts MEF2-DNA binding, potentially influencing MEF-2C activity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII), a kinase implicated in MEF-2C regulation. By inhibiting CaMKII, KN-93 disrupts the downstream signaling events, potentially influencing MEF-2C activation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AICAR is an activator of AMP-activated protein kinase (AMPK). By activating AMPK, AICAR influences cellular energy homeostasis and potentially modulates MEF-2C activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a specific inhibitor of MEK1, a component of the MAPK/ERK signaling pathway. MEF-2C activity is influenced by the MAPK/ERK pathway. PD98059 disrupts this pathway, potentially modulating MEF-2C activation. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
DAPT is a selective inhibitor of γ-secretase, a protease involved in Notch signaling. MEF-2C is known to interact with the Notch pathway. By inhibiting γ-secretase, DAPT influences MEF-2C activation through modulation of Notch signaling. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $57.00 $184.00 $867.00 | 10 | |
BIO is a selective glycogen synthase kinase-3 (GSK-3) inhibitor. MEF-2C is known to be regulated by GSK-3. By inhibiting GSK-3, BIO influences downstream signaling events, potentially modulating MEF-2C activation. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
CHIR99021 is a selective inhibitor of glycogen synthase kinase-3 (GSK-3). MEF-2C is known to be regulated by GSK-3. By inhibiting GSK-3, CHIR99021 influences downstream signaling events, potentially modulating MEF-2C activation. |